At Maddox Pharma Swiss, quality is defined by precision, discipline, and continuous oversight across the entire product lifecycle. Each batch undergoes rigorous quality control testing by our qualified QC team, while our Quality Assurance specialists ensure that all processes, equipment, and environments consistently meet the highest standards.
Our QA and QC departments are responsible for the qualification and continuous evaluation of manufacturing partners and their products through comprehensive documentation review and on-site audits conducted by our responsible pharmacists. Product approval is granted only after full dossier assessment in accordance with regulatory requirements.
Batch release is performed only after thorough evaluation, including detailed visual inspection of both product and packaging, supported by complete and verified certificates of analysis. This integrated approach ensures consistent quality, safety, and reliability across our portfolio.

Maddox Pharma Swiss B.V. has established strong and long-standing relationships with selected European manufacturing partners. All suppliers are required to comply with Good Manufacturing Practice (GMP) standards and to provide valid manufacturing licenses, supported by comprehensive documentation including Site Master Files and detailed quality questionnaires. Suppliers are qualified and approved by our responsible pharmacists, with ongoing oversight to ensure continued compliance.Our QA and QC departments are responsible for the qualification and continuous evaluation of manufacturing partners and their products through comprehensive documentation review and on-site audits conducted by our responsible pharmacists. Product approval is granted only after full dossier assessment in accordance with regulatory requirements.
Batch release is performed only after thorough evaluation, including detailed visual inspection of both product and packaging, supported by complete and verified certificates of analysis. This integrated approach ensures consistent quality, safety, and reliability across our portfolio.

At Maddox Pharma Swiss, patient safety is our highest priority. Our Pharmacovigilance (PV) system is dedicated to the continuous monitoring, detection, assessment, and prevention of adverse effects associated with our pharmaceutical products throughout their lifecycle. Our PV activities are managed and overseen by EU-qualified Pharmacovigilance experts (QPPV), ensuring compliance with European regulations and international safety standards, and enabling timely identification and evaluation of safety signals.

In line with the European Pharmacovigilance framework, all medicinal products undergo strict evaluation of quality, efficacy, and safety prior to authorization and remain under continuous monitoring once on the market to ensure that any impact on the benefit-risk profile is promptly identified and addressed. This structured approach ensures the ongoing safety, effectiveness, and reliability of our products worldwide.Batch release is performed only after thorough evaluation, including detailed visual inspection of both product and packaging, supported by complete and verified certificates of analysis. This integrated approach ensures consistent quality, safety, and reliability across our portfolio.